New developments in atrial antiarrhythmic drug therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Link
http://www.nature.com/articles/nrcardio.2009.245.pdf
Reference143 articles.
1. Fuster, V. et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J. Am. Coll. Cardiol. 48, 854–906 (2006).
2. Reiffel, J. A. Rate versus rhythm control pharmacotherapy for atrial fibrillation: where are we in 2008? JAFIB 1, 31–47 (2008).
3. Naccarelli, G. V. & Gonzalez, M. D. Atrial fibrillation and the expanding role of catheter ablation: do antiarrhythmic drugs have a future? J. Cardiovasc. Pharmacol. 52, 203–209 (2008).
4. Roux, J. F. et al. Antiarrhythmics after ablation of atrial aibrillation (5A Study). Circulation 120, 1036–1040 (2009).
5. Cain, M. E. & Curtis, A. B. Rhythm control in atrial fibrillation—one setback after another. N. Engl. J. Med. 358, 2725–2727 (2008).
Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mild elevation of extracellular potassium greatly potentiates the effect of sodium channel block to cardiovert atrial fibrillation: The Lankenau approach;Heart Rhythm;2023-09
2. Polypharmacology in Clinical Applications: Cardiovascular Polypharmacology;Polypharmacology;2022
3. Investigational Anti–Atrial Fibrillation Pharmacology and Mechanisms by Which Antiarrhythmics Terminate the Arrhythmia: Where Are We in 2020?;Journal of Cardiovascular Pharmacology;2020-11
4. Injectable Drug‐Releasing Microporous Annealed Particle Scaffolds for Treating Myocardial Infarction;Advanced Functional Materials;2020-09-06
5. How a concentration-effect analysis of data from the eliglustat thorough electrocardiographic study was used to support dosing recommendations;Molecular Genetics and Metabolism;2020-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3